Get Live Data

The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Latest Share Chat

  2. Share Prices
  3. Alliance Pharma Share Price
  4. Alliance Pharma Share Regulatory News
  5. Director Share options

Pin to quick picksAlliance Pharma Regulatory News (APH)

Alliance Pharma Information

Share Price Information for Alliance Pharma (APH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 39.25
Bid: 39.00
Ask: 39.30
Change: 0.65 (1.68%)
Spread: 0.30 (0.769%)
Open: 37.00
High: 40.00
Low: 37.00
Prev. Close: 38.60
APH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director Share options

16 Apr 2009 10:48

RNS Number : 6736Q
Alliance Pharma PLC
16 April 2009
 



For Immediate Release

16 April 2009

ALLIANCE PHARMA PLC

("the Company")

Share Options

Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, announces that on 14 April 2009 it awarded the following options over ordinary shares of the Company to certain Directors.

Name

Position

Number of options awarded

Exercise price per share

Date of vesting

Percentage of issued ordinary share capital

Tony Booley

Sales & Marketing Director

110,000

7.75p

14 April 2012

0.07%

Richard Wright

Finance Director

113,000

7.75p

14 April 2012

0.07%

For further information: 

Alliance Pharma plc
+ 44 (0) 1249 466966
John Dawson, Chief Executive
 
Richard Wright, Finance Director
 

www.alliancepharma.co.uk
 
 
 
Buchanan Communications
+ 44 (0) 20 7466 5000
Mark Court / Rebecca Skye Dietrich / Stasa Filiplic
 
 
 
Numis Securities
+ 44 (0) 20 7260 1000
Nominated Adviser: Michael Meade / Brent Nabbs
 
Corporate Broking: David Poutney
 

 

Notes to editors

About Alliance Pharma

Alliance Pharma, founded in 1998, is an AIM listed speciality pharmaceutical company based in Chippenham, Wiltshire, UK. The company has a strong track record of acquiring the rights to established niche brands and owns, or licences, the rights to 35 branded pharmaceutical products and continues to explore opportunities to expand the range.

Alliance Pharma's products are prescribed in the treatment of a wide range of conditions and include brands used in the treatment of dermatological conditions, in childbirth, in the prevention of heart disease, in Parkinson's disease, in nutrition and in nasal infections. Alliance Pharma's sales are mainly prescription driven. Its products are distributed to hospitals directly and to pharmaceutical wholesalers which service both hospital and retail pharmacies with their prescription requirements.

Alliance Pharma joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSUNSKRKSRSARR
567891011121314
Date   Source Headline
10th Apr 201212:01 pmRNSNotice of AGM
27th Mar 20129:00 amRNSAnnual Report and Accounts
22nd Mar 20127:00 amRNSPreliminary Results
21st Mar 20121:00 pmRNSCULS Conversion
8th Mar 20124:00 pmRNSCULS Conversion
2nd Feb 20127:00 amRNSNotification of Preliminary Results
16th Jan 20127:00 amRNSPre-Close Trading Update
19th Dec 20117:00 amRNSAcquisition of Brands
21st Oct 20115:56 pmRNSExercise of Options
21st Sep 20113:30 pmRNSExercise of Options
16th Sep 20112:22 pmRNSExercise of Options
7th Sep 201110:53 amRNSInterim Dividend
7th Sep 20117:01 amRNSAcquisition
7th Sep 20117:00 amRNSInterim Results
10th Aug 20111:20 pmRNSNotification of major interest in shares
9th Aug 20117:00 amRNSNotification of Major Interest in Shares
3rd Aug 20117:00 amRNSNotice of Interim Results
6th Jul 20117:00 amRNSPre-Close Trading Update
16th Jun 20115:59 pmRNSNotification of Major Interest in Shares
10th Jun 20119:41 amRNSExercise of Share Options
7th Jun 20115:21 pmRNSCULS Conversion
26th May 20115:32 pmRNSExercise of Share Options
26th May 20117:00 amRNSAGM Statement
24th May 20114:02 pmRNSExercise of Share Options
20th May 20117:00 amRNSExercise of Share Options
17th May 20117:00 amRNSRenewal of Agreement
13th May 20114:25 pmRNSMajor Interest in Shares
6th May 20114:58 pmRNSExercise of Share Options
28th Apr 20115:40 pmRNSExercise of Options
28th Apr 20114:46 pmRNSShare Options
28th Apr 20117:00 amRNSCULS Conversion
20th Apr 20114:02 pmRNSAnnual Report and AGM Notice
19th Apr 20113:40 pmRNSDirector Shareholding
19th Apr 20112:27 pmRNSCompletion of Acquisition
13th Apr 20114:13 pmRNSNotification of Interest in Shares
23rd Mar 20117:01 amRNSProposed Acquisition
23rd Mar 20117:00 amRNSPreliminary Results
15th Mar 20117:00 amRNSCULS Conversion
2nd Feb 201112:38 pmRNSMajor Interest in Shares
25th Jan 201111:26 amRNSExercise of Options
25th Jan 20118:50 amRNSCULS Conversion
21st Jan 20115:49 pmRNSMajor Interest in Shares
12th Jan 20117:00 amRNSPre-close Trading Update
11th Jan 20111:43 pmRNSCULS Conversion
20th Dec 201010:11 amRNSCULS Conversion
3rd Dec 20104:45 pmRNSNotice of Major Interest in Shares
25th Nov 20102:06 pmRNSCULS Conversion
25th Nov 20107:00 amRNS£44 million Bank Facilities
15th Nov 20104:24 pmRNSMajor Interests in Shares
9th Nov 20108:44 amRNSCULS Conversion and Additional Listing
567891011121314

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.